Impact of delaying botulinum toxin treatment in patients with migraine during the COVID-19 pandemic

Background  Due to coronavirus disease 2019 (COVID-19) pandemic response measures, the administration of botulinum toxin (BTX) was delayed for many patients during the first lockdown period in Portugal. Objectives  To review the impact of postponing BTX treatment on migraine control. Methods  This w...

Descripción completa

Detalles Bibliográficos
Autores principales: Nascimento, Henrique, Videira, Gonçalo, Duarte, Sara, Correia, Carlos, Andrade, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104750/
https://www.ncbi.nlm.nih.gov/pubmed/37059434
http://dx.doi.org/10.1055/s-0043-1763490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104750/
https://www.ncbi.nlm.nih.gov/pubmed/37059434
http://dx.doi.org/10.1055/s-0043-1763490

Ejemplares similares